|
⚲
|
| Keyboard |
| Aberdare Management Company LLC
✚
|
|
|---|---|
| CRD # | 163520 |
| SEC # | 802-76128 |
| CIK # | 0001433057, 0001334248, 0001744257, 0001582419, 0000935463, 0001313414 |
| AUM | |
| Employees | |
| Fees | |
| Minimum | |
| Phone | 415-392-7442 |
| Address | 38 Keyes Avenue San Francisco, CA 94129 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Aberdare II Annex Fund LP | 2012-03-30 | 5.3 M | |
| VC | Aberdare Ventures II Bermuda LP | 2012-03-30 | 0.2 M | |
| VC | Aberdare Ventures III LP | 2012-03-30 | ||
| VC | Aberdare Ventures II LP | 2012-03-30 | 8.8 M | |
| VC | Aberdare Ventures IV LP | [2012-03-30] | 28.6 M |
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Limited Partners | 2011 - 2026 |
|---|---|
| California Public Employees' Retirement System |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0000935463] | |
| 4 | [0000935463] | |
| 3 | [0001313414] | |
| 4 | [0001313414] | |
| SC 13G | [0001313414] | |
| 3 | [0001334248] | |
| 4 | [0001334248] | |
| SC 13D | [0001433057] | |
| 3 | [0001582419] | |
| 4 | [0001582419] | |
| 3 | [0001744257] | |
| 4 | [0001744257] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Aberdare Ventures III LP | Nevro Corp | [2015-02-13] |
| Aberdare Ventures III LP | Conatus Pharmaceuticals Inc | [2014-02-13] |
| Aberdare Ventures IV LP | Clovis Oncology Inc | [2012-04-04] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2021-06-10 | Grant | 42,223 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2020-06-04 | Grant | 40,138 | $0.00 | |
|
Clovis Oncology Inc CLVS
Common Stock
|
2019-07-29 | Option exercise | 25,862 | $0.29 | 7,500 |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2019-07-29 | Option exercise | 25,862 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2019-06-06 | Grant | 28,882 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2018-10-11 | Grant | 14,770 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Common Stock
|
2018-06-25 | Conversion | 31,481 | ||
|
Kezar Life Sciences Inc KZR
Series B Convertible Preferred Stock · derivative
|
2018-06-25 | Conversion | 31,481 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Common Stock
|
2018-06-25 | Conversion | 105,162 | ||
|
Kezar Life Sciences Inc KZR
Series A Convertible Preferred Stock · derivative
|
2018-06-25 | Conversion | 105,162 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2017-06-08 | Grant | 10,000 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2016-06-09 | Grant | 10,000 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2015-06-11 | Grant | 10,000 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (right to buy) · derivative
|
2014-06-12 | Grant | 12,414 | $0.00 | |
|
Anacor Pharmaceuticals Inc ANAC
Stock Option (right to buy) · derivative
|
2014-05-29 | Grant | 15,000 | $0.00 | |
|
Histogen Inc CNAT
Common Stock
|
2014-02-19 | Other | 36,634 | $0.00 | |
|
Histogen Inc CNAT
Common Stock
|
2014-02-19 | Other | 30,216 | $0.00 | |
|
Histogen Inc CNAT
Common Stock
|
2014-02-19 | Other | 1,283,589 | $0.00 | |
|
Histogen Inc CNAT
Common Stock
|
2014-02-19 | Other | 20,322 | $0.00 | |
|
Histogen Inc CNAT
Common Stock
|
2014-02-19 | Other | 8,731 | $0.00 | |
| showing 20 of 98 most recent transactions | |||||